McKesson (NYSE:MCK) is a leading global healthcare services and pharmaceutical distribution company. It provides essential products and services that help pharmacies, hospitals and healthcare providers manage the commercial supply chain for pharmaceuticals and medical devices. The company’s offerings span brand-name and generic drugs, biologics, vaccines, over-the-counter remedies and specialty pharmaceuticals. McKesson also supports patient care through technology solutions designed to optimize clinical workflows and supply chain operations.
The firm operates through two primary segments: pharmaceutical distribution and medical-surgical distribution. Its pharmaceutical distribution network supplies medicines and specialty therapies to retail pharmacies, hospital systems and physician practices. The medical-surgical segment delivers a broad portfolio of medical supplies, laboratory products and care management software to acute care facilities. Beyond distribution, McKesson offers pharmacy automation, electronic health records, data analytics platforms and revenue cycle management tools that aim to improve operational efficiency and clinical outcomes.
Headquartered in Irving, Texas, McKesson serves customers across North America, Europe and the Asia-Pacific region. Regional hubs in Canada, the United Kingdom, Ireland, Germany and China enable the company to navigate local regulations and market dynamics effectively. McKesson’s extensive logistics infrastructure encompasses more than 100 distribution centers, a fleet of temperature-controlled vehicles and integrated delivery networks to ensure timely fulfillment and product integrity.
Founded in 1833 as John McKesson & Robbins, the company evolved from a small retail pharmacy into one of the world’s largest healthcare distributors. Over its history, strategic acquisitions—such as the integration of Change Healthcare—have broadened its technology, analytics and specialty distribution capabilities. Under the leadership of President and Chief Executive Officer Brian Tyler, McKesson continues to prioritize innovation, patient safety and value-based care partnerships to support a rapidly changing healthcare landscape.
